Elicio Therapeutics ELTX
NASDAQ ELTX
$1.90 -0.04 (-2.06%)
At close: Oct 23, 2026 · 4:00 PM EDT

Elicio Therapeutics (ELTX) Cost of Revenue (2020 - 2021)

Updated

Elicio Therapeutics (ELTX) reported Cost of Revenue of $433,000 for Q4 2021, up 243.7% from $126,000 a year earlier.

Analysis

Elicio Therapeutics (ELTX) Cost of Revenue (2020 - 2021) Analysis & Trends

Dating back to Q1 2020, Elicio Therapeutics' Cost of Revenue record includes 5 quarters.

  • By year, Cost of Revenue came in at $1.19 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 Elicio Therapeutics 41.61 Mn -36.01 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 433,000.00
Dec 31, 2020 126,000.00
Sep 30, 2020 348,000.00
Jun 30, 2020 333,000.00
Mar 31, 2020 383,000.00
API Access

Elicio Therapeutics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ELTX&period=max&api_key=YOUR_API_KEY